Severe Ehrlichia chaffeensis infection in a lung transplant recipient: a review of ehrlichiosis in the immunocompromised patient. Emerg Infect Dis 2002 Mar;8(3):320-3
Date
04/03/2002Pubmed ID
11927032Pubmed Central ID
PMC2732464DOI
10.3201/eid0803.010249Scopus ID
2-s2.0-0036196045 (requires institutional sign-in at Scopus site) 50 CitationsAbstract
We describe a case of human ehrlichiosis in a lung transplant recipient and review published reports on ehrlichiosis in immunocompromised patients. Despite early therapy with doxycycline, our patient had unusually severe illness with features of thrombotic thrombocytopenic purpura. Of 23 reported cases of ehrlichiosis in immunocompromised patients, organ failure occurred in all patients and 6 (25%) died.
Author List
Safdar N, Love RB, Maki DGMESH terms used to index this publication - Major topics in bold
AdultAnti-Bacterial Agents
Doxycycline
Ehrlichia chaffeensis
Ehrlichiosis
Humans
Lung Transplantation
Male
Postoperative Complications









